ZA95908B - A synergistic formulation for treatment of rheumatic diseases - Google Patents

A synergistic formulation for treatment of rheumatic diseases

Info

Publication number
ZA95908B
ZA95908B ZA95908A ZA95908A ZA95908B ZA 95908 B ZA95908 B ZA 95908B ZA 95908 A ZA95908 A ZA 95908A ZA 95908 A ZA95908 A ZA 95908A ZA 95908 B ZA95908 B ZA 95908B
Authority
ZA
South Africa
Prior art keywords
treatment
rheumatic diseases
synergistic formulation
synergistic
formulation
Prior art date
Application number
ZA95908A
Inventor
Joshi Yeshwant Dr Kashinath
Original Assignee
Joshi Yeshwant Dr Kashinath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joshi Yeshwant Dr Kashinath filed Critical Joshi Yeshwant Dr Kashinath
Priority to ZA95908A priority Critical patent/ZA95908B/en
Publication of ZA95908B publication Critical patent/ZA95908B/en

Links

ZA95908A 1995-02-06 1995-02-06 A synergistic formulation for treatment of rheumatic diseases ZA95908B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA95908A ZA95908B (en) 1995-02-06 1995-02-06 A synergistic formulation for treatment of rheumatic diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA95908A ZA95908B (en) 1995-02-06 1995-02-06 A synergistic formulation for treatment of rheumatic diseases

Publications (1)

Publication Number Publication Date
ZA95908B true ZA95908B (en) 1995-10-13

Family

ID=25584796

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA95908A ZA95908B (en) 1995-02-06 1995-02-06 A synergistic formulation for treatment of rheumatic diseases

Country Status (1)

Country Link
ZA (1) ZA95908B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638540B2 (en) 1997-05-06 2003-10-28 Universitat Bern Plant extracts for the treatment of increased bone resorption
US7141253B2 (en) * 2002-11-14 2006-11-28 Board Of Trustees Of Michigan State University Cyclooxygenase-2 inhibitory withanolide compositions and method
US20090060883A1 (en) * 2001-12-11 2009-03-05 Nestec S.A. Composition for promotion of bone growth and maintenance of bone health
US20120021077A1 (en) * 2007-07-18 2012-01-26 Bhushan Patwardhan Synergistic herbal composition for treatment of rheumatic and musculo-skeletal disorders (rmsds)
CN104853761A (en) * 2012-10-23 2015-08-19 皮拉马尔企业有限公司 Herbal composition for the prevention and treatment of tnf-alpha mediated diseases

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638540B2 (en) 1997-05-06 2003-10-28 Universitat Bern Plant extracts for the treatment of increased bone resorption
US20090060883A1 (en) * 2001-12-11 2009-03-05 Nestec S.A. Composition for promotion of bone growth and maintenance of bone health
US7141253B2 (en) * 2002-11-14 2006-11-28 Board Of Trustees Of Michigan State University Cyclooxygenase-2 inhibitory withanolide compositions and method
US7195784B2 (en) * 2002-11-14 2007-03-27 Board Of Trustees Of Michigan State University Cyclooxygenase-2 inhibitory withanolide compositions and method
US20120021077A1 (en) * 2007-07-18 2012-01-26 Bhushan Patwardhan Synergistic herbal composition for treatment of rheumatic and musculo-skeletal disorders (rmsds)
CN104853761A (en) * 2012-10-23 2015-08-19 皮拉马尔企业有限公司 Herbal composition for the prevention and treatment of tnf-alpha mediated diseases
US20150265651A1 (en) * 2012-10-23 2015-09-24 Piramal Enterprises Limited Herbal Composition for the Prevention and Treatment of TNF-ALPHA Mediated Diseases

Similar Documents

Publication Publication Date Title
EP0831845A4 (en) Diphosphonate derivatives of therapeutic agents
HK1009939A1 (en) Medicament for treating cardiac inflammatory diseases
AU5178296A (en) Induction of e-selectin for targetting therapeutic agents
AU7715491A (en) A therapeutic preparation containing myrrh for treating skin disorders
IL119894A (en) Use of thiazolidine in the preparation of a medicament for the treatment of osteoporosis
AU2027695A (en) Pharmaceutical composition for treating stoma-peripheral inflammation diseases
PL310348A1 (en) Substituted derivatives of azolone for use in treating diseases caused by heliobacter
HUP9900147A2 (en) Therapeutic agents and pharmaceutical compositions for treatment of autoimmune diseases
HUP9901303A3 (en) A pharmaceutical composition for the treatment of autoimmune diseases
ZA95908B (en) A synergistic formulation for treatment of rheumatic diseases
EP0765661A3 (en) Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis
AU3263795A (en) Medicament for treatment or prophylaxis of incontinence
AU6460696A (en) Use of n-cyclohexyl benzamides for treating bowel disorders
AU697136B2 (en) Agents for treating metabolic bone diseases
AU4819993A (en) Drug for treatment and prophylaxis of bone and joint diseases
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
IL117465A (en) Use of certain cystine derivatives for the preparation of a medicament for the treatment of restenosis
ZA944671B (en) Medicaments for the treatment of inflammatory diseases
HUP0104619A3 (en) Use of pde inhibitors in the manufacture of a medicament for the treatment of bladder diseases
AU9166598A (en) Use of sulphonanilide derivatives to obtain a medicine for treating retrograde ejaculation or aspermia
GB9523066D0 (en) Compounds and their therapeutic use
GB2266241B (en) Treatment of pastures
SI0858337T1 (en) A pharmaceutical composition for the treatment of autoimmune diseases
AU7340894A (en) Treatment of oral ailments
IL107493A0 (en) A device and method for the treatment of rheumatic diseases